sever
acut
respiratori
syndrom
sar
novel
infecti
diseas
first
occur
novemb
china
sar
caus
newli
emerg
viru
belong
coronavirida
famili
provision
term
sarscoronaviru
sarscov
avail
sequenc
data
indic
sarscov
clearli
differ
previous
known
coronavirus
new
fourth
genet
lineag
propos
sarscov
although
other
suggest
may
earli
splitoff
group
lineag
although
humantohuman
transmiss
sarscov
less
effici
exampl
influenza
virus
recent
sar
epidem
characteris
sever
explos
outbreak
case
result
direct
transmiss
via
respiratori
droplet
close
person
contact
adequ
respiratori
protect
measur
shown
effect
howev
number
instanc
transmiss
occur
mean
often
still
well
defin
hotel
episod
case
occur
individu
never
met
sarsinfect
individu
facetofac
amoy
garden
highris
hous
estat
transmiss
probabl
occur
sarscov
shed
faec
patient
mainland
china
around
probabl
sar
patient
appar
histori
close
person
contact
anoth
case
least
proport
case
might
arisen
mode
transmiss
droplet
wear
face
mask
singl
import
precaut
sar
hospit
set
practic
interest
studi
stabil
viru
differ
condit
encount
variou
environ
addit
valid
chemic
physic
mean
render
sarscov
noninfecti
import
given
remot
related
sarscov
may
well
behav
differ
coronavirus
therefor
studi
stabil
sarscov
suspens
dri
surfac
comparison
sarscov
isol
obtain
sputum
patient
hospitalis
diagnosi
probabl
sar
isol
unit
frankfurt
univers
hospit
germani
herp
simplex
viru
type
strain
mcintyr
human
adenoviru
type
obtain
american
type
cultur
collect
atcc
manassa
va
usa
atcc
no
human
coronaviru
strain
kindli
provid
dr
j
ziebuhr
univers
germani
sarscov
adenoviru
grown
vero
cell
cultur
african
green
monkey
kidney
atcc
human
coronaviru
propag
human
embryon
lung
fibroblast
atcc
mainten
medium
consist
minimum
essenti
medium
mem
without
fetal
calf
serum
fc
contain
iuml
penicillin
streptomycin
viru
stock
store
infecti
viru
titr
determin
tissu
cultur
infect
dose
confluent
cell
microtitr
plate
accord
recommend
work
involv
infecti
sarscov
perform
biosafeti
level
bsl
condit
facil
viru
infect
variou
pretreat
assess
perform
viru
titrat
assess
viru
stabil
solut
cell
cultur
supernat
contain
known
concentr
infecti
viru
kept
differ
condit
assess
efficaci
thermal
inactiv
procedur
solut
incub
without
fc
protein
addit
min
addit
viru
suspens
appli
polystyren
petri
dish
diamet
cm
left
dri
room
temperatur
rt
thereaft
dish
store
rt
differ
period
time
dri
viru
resuspend
mem
residu
sarscov
infect
detect
recognit
cytopath
effect
cpe
vero
cell
addit
immunostain
infect
cell
use
convalesc
serum
sar
patient
fig
describ
sarscovinfect
vero
cell
fix
onto
microscop
slide
immunofluoresc
assay
cell
fix
differ
period
time
use
aceton
alon
acetonemethanol
mixtur
ethanol
ethanol
mixtur
ethanol
phosphat
buffer
salin
pb
storag
h
cell
scratch
slide
resuspend
mem
inocul
onto
confluent
vero
cell
monolay
flask
incub
interv
cell
passag
two
passag
flask
microscop
examin
virusspecif
cpe
immun
peroxidas
stain
perform
describ
previous
follow
compound
test
roth
karlsruh
germani
desderman
n
ethanol
mayr
norderstedt
germani
sterillium
bode
chemi
hamburg
germani
formaldehyd
glutardialdehyd
merck
darmstadt
germani
incidin
plu
contain
glucoprotamin
henkelecolab
germani
addit
wine
vinegar
acid
concentr
sugar
concentr
wv
doktorenhof
venningen
germani
might
use
hand
disinfect
spray
inhal
analys
experi
eight
part
compound
adapt
rt
mix
one
part
viru
suspens
one
part
fc
mem
respect
immedi
incub
defin
period
time
rt
mixtur
put
ice
bath
avoid
extens
effect
incub
period
serial
dilut
icecold
mem
done
assess
viru
titr
describ
test
perform
triplic
experi
viru
control
contain
mem
instead
disinfect
includ
cytotox
effect
disinfect
still
present
dilut
virusdisinfect
mixtur
membranefiltr
incub
use
amicon
filter
unit
kda
millipor
schwalbach
germani
accord
manufactur
instruct
increas
viru
concentr
approxim
whilst
retain
concentr
disinfect
becam
possibl
assess
reduct
viru
titr
despit
agent
cytotox
cytotox
effect
caus
compound
variou
dilut
assess
confluent
layer
vero
cell
grown
plate
use
mtt
cell
prolif
kit
roch
mannheim
germani
publish
previous
figur
show
declin
infecti
viru
titr
four
virus
test
time
suspens
fig
dri
fig
b
presenc
fc
protein
addit
fig
b
protein
ad
fig
c
experi
kept
rt
residu
infecti
titr
test
differ
timepoint
h
h
h
h
day
day
postinfect
suspens
gradual
lost
infect
three
virus
includ
sarscov
stabl
entir
durat
experi
addit
fc
effect
dri
state
gradual
loss
infect
observ
four
virus
test
sensit
complet
lost
infect
within
h
without
ad
fc
agreement
previou
studi
contrast
dri
sarscov
retain
infect
long
day
fc
exert
protect
influenc
throughout
day
dri
state
sarscov
complet
lost
infect
adenoviru
type
stabl
amongst
virus
test
retain
infect
late
day
experi
termin
effect
exposur
differ
temperatur
influenc
protein
addit
infect
sarscov
present
tabl
heat
treatment
min
reduc
viru
titr
detect
limit
howev
presenc
fc
reduct
factor
instead
incub
min
result
infecti
viru
remain
regardless
presenc
protein
addit
control
loss
infecti
titr
evalu
efficaci
differ
commonli
use
fixat
procedur
elimin
infect
sarscov
show
initi
viru
titr
residu
infect
detect
fixat
icecold
aceton
icecold
acetonemethanol
mixtur
min
ethanol
min
ethanol
min
howev
fixat
mixtur
pb
ethanol
min
lowlevel
residu
infect
observ
quantifi
four
commonli
use
brand
hand
disinfect
abl
render
sarscov
noninfecti
within
sec
contact
tabl
present
data
sarscovirucid
efficaci
isopropanol
achiev
reduct
viru
infect
desderman
reduc
viru
titr
sterillium
actual
reduct
factor
shown
vari
effect
ultrafiltr
necessit
differ
cytotox
compound
addit
three
disinfect
formaldehyd
glutardialdehyd
incidin
plu
assess
antisarscov
potenc
three
render
sarscov
noninfecti
minimum
reduct
factor
formaldehyd
glutardialdehyd
incidin
plu
min
incub
reduct
factor
wine
vinegar
achiev
within
although
sar
outbreak
seem
halt
time
indic
stringent
control
measur
taken
prevent
persontoperson
transmiss
effect
remain
import
assess
risk
mode
spread
exampl
via
fomit
excret
report
member
laboratori
sar
network
indic
viru
stabl
faec
urin
rt
least
day
even
stabl
day
stool
patient
diarrhoea
higher
ph
normal
stool
howev
neither
time
requir
complet
inactiv
quantit
data
report
data
allow
meaning
interpret
compar
behaviour
sarscov
import
humanpathogen
virus
consider
proport
probabl
sar
case
china
direct
close
contact
anoth
sar
patient
could
elucid
thu
least
case
may
arisen
indirect
transmiss
therefor
import
obtain
inform
tenac
sarscov
environ
differ
condit
furthermor
critic
assess
effici
commonli
use
disinfect
method
abl
reliabl
inactiv
sarscov
experiment
data
show
sarscov
consider
stabl
previous
identifi
human
coronaviru
dri
state
sarscov
retain
residu
infect
even
day
complet
lost
infect
within
h
thermal
inactiv
sarscov
highli
effect
howev
presenc
protein
infect
reduc
less
min
also
min
data
shown
implic
handl
clinic
specimen
sar
patient
exampl
pretreat
sera
min
might
suffici
full
inactiv
hand
sarscov
viraemia
seem
reach
high
titr
moder
reduct
residu
infect
might
suffici
enabl
safe
perform
serolog
laboratori
assay
anoth
question
practic
import
concern
absenc
infect
chemic
fix
sarscovinfect
cell
indirect
immunofluoresc
assay
ifa
wide
utilis
detect
sarscovspecif
antibodi
patient
sera
normal
carri
limit
safeti
condit
instead
demonstr
one
except
pbsethanol
min
fix
abl
elimin
infect
summari
shown
despit
consider
higher
environment
stabil
compar
previous
characteris
human
coronaviru
sarscov
easili
inactiv
thermal
chemic
born
mind
case
sar
reemerg
often
critic
clinic
state
sar
patient
requir
frequent
determin
standard
haematolog
clinic
chemistri
paramet
may
done
confid
provid
standard
infect
safeti
precaut
adher
data
present
contribut
better
understand
stabil
sarscov
differ
environment
situat
also
demonstr
efficaci
variou
mean
sarscov
inactiv
contribut
improv
laboratori
safeti
